NCT02605928

Use of BIP-Needles in Rheumatologic Injections

INJ-INAR-01 Use of BIP-Needles in Rheumatologic Injections

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 79 (actual)
• Sponsor: Injeq Ltd · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The study focuses on needle guidance in rheumatologic operations - glucocorticoid injections inside joint capsules specifically. The main purpose of the study is to assess and validate the clinical feasibility and performance of Bioimpedance Probe (BIP) Needles and assess the benefits, drawbacks and risks related to use of the BIP Needles.

Detailed description

Clinical device investigation

Conditions

• Intra-articular Injections

Interventions

Type	Name	Description
DEVICE	Injeq Bioimpedance Probe (BIP) Needle	Injeq Bioimpedance Probe (BIP) Needle is an injection needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with synovial fluid.

Timeline

• Start date: 2014-10-01
• Primary completion: 2015-05-01
• Completion: 2016-01-01
• First posted: 2015-11-17
• Last updated: 2017-04-04
• Results posted: 2017-04-04

Locations

1 site across 1 country: Finland